This clinic is a medical partner of Mirai Medical Group. For more information, please visit Mirai Medical Group.


Launch of personalized mailing kit that “predicts through AI the risk of developing 13 diseases” based on cohort data obtained from 5 million people. 〜Launch of AI Disease Prediction Kit- Risk Check〜

Mirailab Bioscience, Inc. (HQ: Chuo-ku, Tokyo; CEO: Megumi Tanaka) is proud to announce we will release our second product in our health mailing analysis series, AI Disease Prediction Kit- Risk Check, on December 15, 2022. This kit uses DX Care Check, a service that applies AI to predict the future risk of developing 13 types of diseases and is provided by DX CARE (HQ: Shinjuku, Tokyo; CEO: Tatsuki Shimizu). The results can be used for future health management.

To celebrate the launch of this kit, we are offering a limited-time exclusive discount if you purchase this kit together with our first product in our series of health mailing analysis (Mitochondria Quantitation Kit- Energy Check1 ; regular price: 16,500 yen). You can acquire the two sets for the special price of 20,000 yen, instead of the usual 23,000 yen. Please visit our store here: (launch on December 15)

What happens when you buy this kit? Here is a step-by-step explanation.
1) You will be asked to send back to our lab a simple medical questionnaire that’s included in your kit (just mark with a circle the diseases you and your relatives have, and your smoking, drinking, and exercise habits) along with copies of the results of your last three annual general health checkups.
2) Using the information received, we will run an AI simulation2 that determines the probability of disease onset and will calculate the risk you have to develop 13 diseases in the next 4 years (to be counted from the date of your most recent medical checkup). The target diseases are diabetes, cardiac disease, dementia, Alzheimer’s disease, stomach cancer, colon cancer, liver cancer, lung cancer, breast cancer, prostate cancer, stroke, hypertension, and dyslipidemia.
3) The results are provided to the user as a disease prediction report by postal mail or e-mail (see sample image).  

 The disease prediction report displays graphically the predicted risk of disease onset for each disease, lists the health checkup items that influenced the AI-calculated risk prediction in order of influence, and displays the following three points for each item: 1. current status, 2. difference from the reference value, and 3. average value from people of the same age/gender.

The kit will be released on our e-commerce site (, but will also be available for patients that visit the Tokyo Ginza Wellness & Aging Clinic3 (Location: Chuo-ku, Tokyo; Director: Takahiro Otani), for which we provide medical support. Patients who purchase the product at the clinic will receive a disease prediction report and an explanation of the prediction results from the doctor in charge.

Mirailab Bioscience Inc. and Tokyo Ginza Wellness & Aging Clinic aim to cure aging and achieve Productive Aging by: 1. Providing high-quality NMN products (NMN, or nicotinamide mononucleotide, is a substance with an amazing anti-aging potential4); 2. Remote analysis of health conditions by postal mail; 3. High-precision medical examinations and treatment at our in-patient clinic; and 4. Compilation and use of big data.  

We will continue our efforts to contribute to the improvement of the quality of life of as many people as possible as a leading NMN company.

(1) World’s first! Determination of Aging Level by Measuring Mitochondria- Pre-order Your Test Mailing Kit Now!

(2) DX Care Check (DX CARE: Shinjuku, Tokyo) uses a disease onset prediction model that learns from data obtained from a cohort of 5 million people (long-term data of every individual). The DX Care Check system compares the entered medical checkup data with the disease onset prediction model, and calculates the risk of subsequent disease onset as a probability, using statistical methods based on trends and changes in medical checkup results for each age and gender.

(3) Tokyo Ginza Wellness & Aging Clinic

(4) More about nicotinamide mononucleotide (NMN)

For inquiries, please contact Mirailab Bioscience:

Related topics